Now Available! Waters New Quality Parts, Chromatography Columns and Supplies Catalog
April 3, 2012
Milford, Mass.– Waters Corporation (WAT:NYSE) has published its all-new 2012-2013 Waters Quality Parts®, Chromatography Columns and Supplies Catalog. This 400-page, color catalog features thousands of Waters Quality Parts, branded HPLC and UPLC® columns, vials, filters, sample preparation products, and supplies for getting the highest level of performance from LC, LC/MS, UPLC, UPC^2™, GPC, and SFC [...]
Stellar Biotechnologies Launches Stellar KLH™ ELISA Test Kits
April 3, 2012
Stellar KLH™ ELISA Kits are designed for the rapid, quantitative measure of anti-KLH antibodies in serum or plasma samples. Stellar’s product launch includes six different kits to measure either IgG or IgM antibodies in a range of preclinical models. The new assay kits are the first anti-KLH ELISA’s (enzyme-linked immunosorbent assays) made with the Company’s [...]
The Partnership Provides Expanded Access to the Award Winning MAGPIX® Multiplexing Instrument
April 3, 2012
AUSTIN, Texas,-- Luminex Corporation (NASDAQ: LMNX) today announced that it has extended its global sales and distribution agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to 2023. In addition, Luminex has granted Bio-Rad global sales and distribution rights for Luminex's award-winning MAGPIX multiplexing instrument. As part of the agreement, Bio-Rad will now offer the [...]
April 3, 2012
BALTIMORE,-- InstantLabs Medical Diagnostics Corporation (InstantLabs®), developer of the portable Hunter Accelerated Real-Time PCR® system, today announced that its Salmonella Species Food Safety Kit has been certified as Performance-Tested Methods(SM) (PTM) No. 031202 by the AOAC Research Institute (AOAC-RI). The award follows independent laboratory studies conducted by Food Safety Net Services (FSNS). The PTM certification [...]
Roche disappointed by Illumina, Inc.’s Board of Directors’ rejection
April 3, 2012
Roche released the following statement in response to the announcement by Illumina, Inc. (NASDAQ: ILMN) that its Board of Directors has recommended that shareholders not tender their shares to Roche’s increased offer. “We are disappointed that Illumina’s Board of Directors has rejected Roche’s increased $51.00 cash offer and continues to rebuff our attempts to engage [...]
Advanced Photonix, Inc. Signs Value Added Reseller Agreement with ACT
April 3, 2012
ANN ARBOR, Mich.-- Advanced Photonix, Inc.® (NYSE Amex:API) today announced that it has signed a value-added reseller (VAR) for its T-Gauge® industrial terahertz gauging system with Automation and Control Technology, Inc. (ACT). The T-Gauge® measurement system builds on the company's long history of terahertz products dating back over 10 years with the introduction of the [...]
Illumina’s Board of Directors Sends Third Letter to Stockholders
April 3, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a third letter to its stockholders highlighting Illumina’s tremendous growth prospects in the next generation sequencing market. The letter urges stockholders to reject Roche’s efforts to [...]
OSAKA UNIVERSITY PURCHASES A NANOINK DPN 5000 SYSTEM
April 3, 2012
CHICAGO – NanoInk’s NanoFabrication Systems Division is pleased to announce that Osaka University’s Photonics Advanced Research Center in Osaka, Japan, has recently purchased and installed a DPN 5000 System – a dedicated, versatile instrument capable of patterning a variety of materials with nanoscale accuracy and precision. Osaka University scientists will harness the power of the [...]
Lonza appoints Richard Ridinger as new CEO
April 3, 2012
Basel, Switzerland, – At a meeting on 2 April 2012, the Board of Directors of Lonza elected Mr. Richard Ridinger as the new CEO of Lonza. Mr. Ridinger will become CEO of Lonza effective 1 May. Rolf Soiron was acting CEO ad interim, since the end of January. Richard Ridinger is 53 years old, a [...]
Knome expands executive management team, positions company for growth
April 3, 2012
CAMBRIDGE, MA – Knome Inc., the human genome interpretation company, today announced that it has continued to strengthen its executive management team, adding Charles Abdalian as Chief Financial Officer, Adam Rosenberg as Senior Vice President and Head of Corporate Development, and Jay Therrien, PhD. as Senior Vice President and Head of Global Sales. “We are [...]
